Clinical Trials List
2026-02-02 - 2031-04-05
Phase III
Recruiting5
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Mei Yueh Lee Division of Endocrinology
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 李純瑩 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hao-min Cheng 教學部
- 游偉光 Division of Ophthalmology
- 林重榮 Division of Radiology
- Tze-Fan Chao Division of Cardiovascular Diseases
- Shih-Hsien Sung 臨床試驗科
- 蔡依霖 Division of General Internal Medicine
- 黃偉銘 Division of Cardiovascular Diseases
- 張皓智 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Huang-Chung Chen Division of Cardiovascular Diseases
- 鍾文榮 Division of Cardiovascular Diseases
- 方修御 Division of Cardiovascular Diseases
- 方燕楠 Division of Cardiovascular Diseases
- 劉文浩 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40-56 participants
-
Global
1980 participants
